Dr. Daubert is a Professor of Medicine with tenure at Duke University School of Medicine, member of the Duke Clinical Research Institute faculty and Associate Director of the Heart Center at Duke University Medical Center. He is ABIM Board Certified in Internal Medicine and Clinical Cardiac Electrophysiology.

Dr. Daubert founded and developed the electrophysiology program at the University of Rochester. He returned to Duke as Chief of the Section of Cardiac Electrophysiology serving until 2019. His research interests include sudden cardiac death, ICD/CRT indications and programming, inherited arrhythmias, sports cardiology and atrial fibrillation. He has served on the MADIT Executive Committees and numerous other steering, events and data monitoring committees. He chaired the Heart Rhythm Society Clinical Cardiology Electrophysiology Program Director Subcommittee and is Vice Chair of the Education Committee.

He was awarded the Simon Dack Award for Outstanding Scholarship from The Journal of the American College of Cardiology (JACC) in 2010, and Elite Reviewer status multiple years. He is the Associate Editor of JACC Clinical Electrophysiology, Senior Consulting Editor at JACC Heart Failure and Associate Editor for The Journal of Interventional Cardiac Electrophysiology. He is on the editorial boards at JACC, Heart Rhythm, The Journal of Interventional Cardiac Electrophysiology, Pacing and Clinical Electrophysiology, The American Journal of Cardiology, The Journal of Electrocardiology and The American Heart Journal. 

Dr. Daubert graduated from Williams College and received a medical degree at Thomas Jefferson University. He received his postgraduate medical training at Duke, serving as chief resident for one year.

As of May 2025, Dr. Daubert reported the following external relationships:

Funding for clinical trial expenses, salary support and staff, paid to Duke University, from the following companies:

• Cardurion, serving as a principal investigator.
• Rocket Pharmaceuticals, serving as a principal investigator. 

Service on data and safety monitoring boards and end-point review committees for the following companies, with honoraria:

• Biosense Webster, for service on an end-point review committee.
• Cordis, for service on an end-point review committee.
• The Medical Center of the University of Rochester, for service as a data and safety monitoring board member.
• Medtronic, for service as chair on an end-point review committee.
• The National Institutes of Health, for service as a data and safety monitoring board member. 

Service on a research-related expert panel or advisory board for the following companies, with honoraria:  

• Boston Scientific, for service on a steering committee, receiving honoraria.
• The Medical Center of the University of Rochester, for serving on a steering committee, without compensation.
• Medtronic, for serving on an advisory board for quality and recalls, receiving honoraria. 

Dr. Daoud is a Professor, Internal Medicine, at the Wexner Medical Center at the Ohio State University and Chief of Cardiac Electrophysiology. He is ABIM Board Certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

Dr. Daoud previously served as Director of Electrophysiology Research with the Midwest Research Foundation and worked as a Clinical Electrophysiologist with MidOhio Cardiology at Riverside Methodist Hospital before joining the Ohio State University in 2007. Prior to that, he was Assistant Professor at the University of Michigan for three years.

Dr. Daoud has published more than 150 manuscripts and has a particular interest in ablation of atrial and ventricular arrhythmias and device therapy, including biventricular pacing, subcutaneous defibrillators and leadless pacing systems. He is a fellow of the American College of Cardiology and a fellow of the Heart Rhythm Society, as well as a member of the American Heart Association. He has been listed as one of America's Best Doctors in U.S. News & World Report and as a Top 10 faculty educator at the Ohio State University Medical Center. He has served on numerous national steering committees and advisory boards.

Dr. Daoud received his undergraduate degree from the University of Notre Dame and a medical degree from the University of Cincinnati. He completed internal medicine training at Johns Hopkins Hospital and cardiology fellowship and subspecialty training in electrophysiology at the University of Michigan.

As of October 2024, Dr. Daoud reported the following external relationships:

Attendance at investigators’ meetings, with compensation for travel expenses and honoraria from the following companies:

• S4Medical, for an esophageal deviation study.

Service on a research-related expert panel or advisory board for the following company, with compensation for travel expenses and honoraria:

• Biosense Webster, advising on design of an investigational device exemption and subsequent clinical trial with new mapping tool for atrial fibrillation rotors.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with compensation for travel expenses and honoraria:

• S4Medical, for an esophageal deviation study

Dr. Daoud serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

• The American College of Cardiology, Editorial Board Member, receiving honoraria. 
• S4Medical, Board Member, inventor of its esophageal protection device for atrial fibrillation ablation procedures, receiving consulting fees and stock equity.

Dr. Lloyd is a Professor of Medicine and the lab director for Emory University Hospital Cardiac Electrophysiology Center. He is the immediate past director of the Electrophysiology Fellowship Program at Emory University and serves as the Vice Chair of the Heart Rhythm Society's Digital Education Committee. He is ABIM Board Certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

As of October 2024, Dr. Lloyd reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Emory University, from the following companies:

• Boston Scientific
• Medtronic

Research-related consulting for the following companies, with compensation for travel expenses and honoraria:  

• Abbott Vascular
• Boston Scientific
• Medtronic 

Dr. Nazer is a cardiac electrophysiologist and Associate Professor of Medicine and Bioengineering at the University of Washington. He is ABIM Board Certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

As of April 2025, Dr. Nazer reported the following external relationships:

Service on a research-related advisory board for the following companies, with compensation for travel expenses and honoraria:

• Biosense Webster
• Siemens